Virus parainfluenza de type 5 : Questions médicales fréquentes
Nom anglais: Parainfluenza Virus 5
Descriptor UI:D045402
Tree Number:B04.820.480.937.600.650.750.800
Termes MeSH sélectionnés :
Interrupted Time Series Analysis
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus parainfluenza de type 5 : Questions médicales les plus fréquentes",
"headline": "Virus parainfluenza de type 5 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus parainfluenza de type 5 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-18",
"dateModified": "2025-03-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus parainfluenza de type 5"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Rubulavirus",
"url": "https://questionsmedicales.fr/mesh/D019213",
"about": {
"@type": "MedicalCondition",
"name": "Rubulavirus",
"code": {
"@type": "MedicalCode",
"code": "D019213",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.480.937.600.650.750"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus parainfluenza de type 5",
"alternateName": "Parainfluenza Virus 5",
"code": {
"@type": "MedicalCode",
"code": "D045402",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Biao He",
"url": "https://questionsmedicales.fr/author/Biao%20He",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Disease, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, United States of America."
}
},
{
"@type": "Person",
"name": "Keisuke Ohta",
"url": "https://questionsmedicales.fr/author/Keisuke%20Ohta",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Medicine, Wakayama Medical University, Wakayama, Japan."
}
},
{
"@type": "Person",
"name": "Machiko Nishio",
"url": "https://questionsmedicales.fr/author/Machiko%20Nishio",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Medicine, Wakayama Medical University, Wakayama, Japan. Electronic address: mnishio@wakayama-med.ac.jp."
}
},
{
"@type": "Person",
"name": "Yusuke Matsumoto",
"url": "https://questionsmedicales.fr/author/Yusuke%20Matsumoto",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Medicine, Wakayama Medical University, Wakayama, Japan."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The effect of COVID-19 on workplace violence in California's hospitals: An interrupted time series analysis.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36762706",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jan.15588"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hurricane Florence and suicide mortality in North Carolina: a controlled interrupted time-series analysis.",
"datePublished": "2022-12-13",
"url": "https://questionsmedicales.fr/article/36600665",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/ip-2022-044709"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Impact of Drought on HIV Care in Rural South Africa: An Interrupted Time Series Analysis.",
"datePublished": "2023-07-31",
"url": "https://questionsmedicales.fr/article/37523018",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10393-023-01647-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "The effect of vaccine mandate announcements on vaccine uptake in Canada: An interrupted time series analysis.",
"datePublished": "2023-04-03",
"url": "https://questionsmedicales.fr/article/37019696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.vaccine.2023.03.040"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of febuxostat on adverse events and mortality in gout in Taiwan: An interrupted time series analysis.",
"datePublished": "2023-01-06",
"url": "https://questionsmedicales.fr/article/36608705",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1756-185X.14558"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Virus à ARN de polarité négative",
"item": "https://questionsmedicales.fr/mesh/D000086103"
},
{
"@type": "ListItem",
"position": 5,
"name": "Mononegavirales",
"item": "https://questionsmedicales.fr/mesh/D018096"
},
{
"@type": "ListItem",
"position": 6,
"name": "Paramyxoviridae",
"item": "https://questionsmedicales.fr/mesh/D010252"
},
{
"@type": "ListItem",
"position": 7,
"name": "Paramyxovirinae",
"item": "https://questionsmedicales.fr/mesh/D018098"
},
{
"@type": "ListItem",
"position": 8,
"name": "Rubulavirus",
"item": "https://questionsmedicales.fr/mesh/D019213"
},
{
"@type": "ListItem",
"position": 9,
"name": "Virus parainfluenza de type 5",
"item": "https://questionsmedicales.fr/mesh/D045402"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus parainfluenza de type 5 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus parainfluenza de type 5",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus parainfluenza de type 5",
"description": "Comment diagnostique-t-on une infection par le virus parainfluenza 5 ?\nQuels tests sont utilisés pour confirmer le virus parainfluenza 5 ?\nLes symptômes aident-ils au diagnostic du virus parainfluenza 5 ?\nPeut-on diagnostiquer le virus parainfluenza 5 par sérologie ?\nLes radiographies sont-elles utiles pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Interrupted+Time+Series+Analysis&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus parainfluenza de type 5",
"description": "Quels sont les symptômes courants du virus parainfluenza 5 ?\nLe virus parainfluenza 5 cause-t-il des complications respiratoires ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes persistent-ils longtemps ?",
"url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Interrupted+Time+Series+Analysis&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus parainfluenza de type 5",
"description": "Comment prévenir l'infection par le virus parainfluenza 5 ?\nLes vaccins protègent-ils contre ce virus ?\nFaut-il éviter les lieux publics en cas d'épidémie ?\nLe port de masque est-il utile ?\nLes enfants doivent-ils être vaccinés contre d'autres virus respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Interrupted+Time+Series+Analysis&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus parainfluenza de type 5",
"description": "Quel est le traitement principal pour le virus parainfluenza 5 ?\nDes antiviraux sont-ils efficaces contre ce virus ?\nQuand faut-il consulter un médecin ?\nLes inhalateurs sont-ils recommandés ?\nLe repos est-il important lors d'une infection ?",
"url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Interrupted+Time+Series+Analysis&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus parainfluenza de type 5",
"description": "Quelles sont les complications possibles du virus parainfluenza 5 ?\nLes personnes âgées sont-elles plus à risque de complications ?\nLe virus peut-il aggraver des maladies préexistantes ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications si elles surviennent ?",
"url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Interrupted+Time+Series+Analysis&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus parainfluenza de type 5",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes maladies respiratoires augmentent-elles le risque ?\nLe tabagisme est-il un facteur de risque ?\nLes nourrissons sont-ils plus à risque ?\nLes conditions de vie affectent-elles le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Interrupted+Time+Series+Analysis&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une infection par le virus parainfluenza 5 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests PCR, cultures virales et des analyses cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le virus parainfluenza 5 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les cultures de prélèvements respiratoires sont les plus courants."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic du virus parainfluenza 5 ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques comme la toux et la fièvre orientent le diagnostic."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer le virus parainfluenza 5 par sérologie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La sérologie n'est pas couramment utilisée pour ce virus, les tests PCR sont préférés."
}
},
{
"@type": "Question",
"name": "Les radiographies sont-elles utiles pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les radiographies peuvent montrer des signes d'infection, mais ne confirment pas le virus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du virus parainfluenza 5 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, fièvre, congestion nasale et difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Le virus parainfluenza 5 cause-t-il des complications respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des complications comme la bronchite ou la pneumonie."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants peuvent présenter des symptômes plus graves que les adultes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à surveiller ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillez la détresse respiratoire et la fièvre élevée, surtout chez les enfants."
}
},
{
"@type": "Question",
"name": "Les symptômes persistent-ils longtemps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent durer de quelques jours à deux semaines selon la gravité."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le virus parainfluenza 5 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Lavez-vous les mains régulièrement et évitez le contact avec des personnes malades."
}
},
{
"@type": "Question",
"name": "Les vaccins protègent-ils contre ce virus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de vaccin spécifique contre le virus parainfluenza 5 actuellement."
}
},
{
"@type": "Question",
"name": "Faut-il éviter les lieux publics en cas d'épidémie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les lieux bondés peut réduire le risque de transmission du virus."
}
},
{
"@type": "Question",
"name": "Le port de masque est-il utile ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter un masque peut aider à réduire la propagation des infections respiratoires."
}
},
{
"@type": "Question",
"name": "Les enfants doivent-ils être vaccinés contre d'autres virus respiratoires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination contre d'autres virus comme la grippe est recommandée."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour le virus parainfluenza 5 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est symptomatique, incluant des antipyrétiques et des bronchodilatateurs."
}
},
{
"@type": "Question",
"name": "Des antiviraux sont-ils efficaces contre ce virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antiviraux spécifiques pour le virus parainfluenza 5."
}
},
{
"@type": "Question",
"name": "Quand faut-il consulter un médecin ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes s'aggravent ou si la respiration devient difficile."
}
},
{
"@type": "Question",
"name": "Les inhalateurs sont-ils recommandés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les inhalateurs peuvent aider à soulager la respiration en cas de bronchospasme."
}
},
{
"@type": "Question",
"name": "Le repos est-il important lors d'une infection ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le repos aide le corps à combattre l'infection et à récupérer plus rapidement."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du virus parainfluenza 5 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la bronchite, la pneumonie et des infections secondaires."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque de complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et immunodéprimées sont plus susceptibles de développer des complications."
}
},
{
"@type": "Question",
"name": "Le virus peut-il aggraver des maladies préexistantes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut aggraver des maladies respiratoires chroniques comme l'asthme."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais peuvent survenir, surtout chez les jeunes enfants."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications si elles surviennent ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent souvent une hospitalisation et un traitement médical intensif."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les jeunes enfants, les personnes âgées et celles avec un système immunitaire affaibli sont à risque."
}
},
{
"@type": "Question",
"name": "Les maladies respiratoires augmentent-elles le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents de maladies respiratoires sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque d'infections respiratoires, y compris parainfluenza."
}
},
{
"@type": "Question",
"name": "Les nourrissons sont-ils plus à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les nourrissons ont un système immunitaire immature, les rendant plus vulnérables."
}
},
{
"@type": "Question",
"name": "Les conditions de vie affectent-elles le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre dans des environnements surpeuplés ou insalubres augmente le risque d'infection."
}
}
]
}
]
}
This study used California's unique Workplace Violent Incident Reporting System (WVIRS) to describe changes in workplace violence (WV) exposure for hospital-based healthcare workers during the pandemi...
Interrupted time series analysis....
We compared the linear trends in weekly WV incidents reported during the period before the COVID-19 pandemic (7/1/2017-3/20/2020) to the period following California's shutdown (3/21/2020-6/30/2021). W...
A total of 418 hospitals reported 37,561 incidents during the study period. For EDs, the number of reported incidents remained essentially constant, despite a 26% drop in outpatient visits between the...
WV persists steadily in California's hospitals. Despite major reductions in patient volume due to COVID-19, weekly reported ED incidents remained essentially unchanged....
Surveys and media reported that WV increased during the pandemic, but it has been difficult to measure these changes using a large-scale database. The absolute number of WV incidents did not increase ...
There was no public contribution to this study. The goal of this analysis was to summarize findings from administrative data. The findings presented can inform future discussion of public policy and a...
Natural disasters are associated with increased mental health disorders and suicidal ideation; however, associations with suicide deaths are not well understood. We explored how Hurricane Florence, wh...
We used publicly available NC death records data to estimate associations between Hurricane Florence and monthly suicide death rates using a controlled, interrupted time series analysis. Hurricane exp...
8363 suicide deaths occurred between January 2014 and December 2019. The overall suicide death rate in NC between 2014 and 2019 was 15.53 per 100 000 person-years (95% CI 15.20 to 15.87). Post-Hurrica...
Although results did not indicate a strong post-Hurricane Florence impact on suicide rates, subgroup analysis suggests differential impacts of Hurricane Florence on several groups, warranting future f...
This analysis investigates the relationship between drought and antiretroviral treatment (ART) adherence and retention in HIV care in the Hlabisa sub-district, KwaZulu-Natal, South Africa. Data on dro...
In 2021, the ten provinces in Canada enacted COVID-19 vaccine mandates that restricted access to non-essential businesses and services to those that could provide proof of full vaccination to decrease...
Aggregated data from the Canadian COVID-19 Vaccination Coverage Surveillance System (CCVCSS) were used to measure vaccine uptake (defined as the weekly proportion of individuals who received at least ...
The times series models demonstrated significant increases in vaccine uptake following mandate announcement in BC, AB, SK, MB, NS, and NL. No trends in the effect of mandate announcements were observe...
Vaccine mandate announcements could have increased vaccine uptake. However, it is difficult to interpret this effect within the larger epidemiological context. Effectiveness of the mandates can be aff...
To evaluate the influence of febuxostat on adverse events and mortality in gout....
We retrospectively enrolled patients with newly diagnosed gout and prescribed urate-lowering therapy between 2006 and 2017 from the Taiwan National Health Insurance Database. These patients were divid...
The proportion of febuxostat use gradually increased from 0% in 2012 to 30% in those with comorbidities and 10% in those without comorbidities in 2017. Allopurinol use decreased from 30% in 2012 to 10...
Febuxostat may reduce SJS and TEN in all gout patients but increase AMI, PCI, and all-cause mortality in gout patients with comorbidities....
To determine death occurrences of Puerto Ricans on the mainland USA following the arrival of Hurricane Maria in Puerto Rico in September 2017....
Cross-sectional study....
Persons of Puerto Rican origin on the mainland USA....
Hurricane Maria....
We use an interrupted time series design to analyse all-cause mortality of Puerto Ricans in the USA following the hurricane. Hispanic origin data from the National Vital Statistics System and from the...
We found an increase in mortality for persons of Puerto Rican origin during the 6-month period following the hurricane (October 2017 through March 2018), suggesting that deaths among these persons wer...
Our findings suggest an undercounting of previous deaths as a result of the hurricane due to the systematic effects on the displaced and resident populations in the mainland USA. Displaced populations...
The growth of parkrun between 2004 and 2019 has been heralded as a success story for public health as a result of its physical activity and wellbeing benefits for participants. However, parkrun was no...
The study combines aggregated parkrun weekly finisher data from 32,470 Lower Layer Super Output Areas (LSOA) in England from January 2015 to February 2023 with Office of National Statistics (ONS) data...
Visualisation and interrupted time series analysis showed a significant and long-term decrease in parkrun participation following the reopening of parkrun events. This was consistent across all IMD qu...
The reduction in parkrun participation during the pandemic and following the reopening of events is likely to have negatively impacted wellbeing in would-be participants. Going forwards, policymakers ...
To analyze epidemiological characteristics of mumps in different periods and explore the impact of different immunization strategies of mumps containing vaccine (MuCV) on the incidence of mumps in Quz...
Beverage and food taxes have become a popular 'best buy' public health intervention in the global battle to tackle noncommunicable diseases. Though many countries have introduced taxes, mainly targeti...
We used weekly electronic point-of-sale data from a major food retailer in Bermuda. We assessed historical weekly sales and price data using an interrupted time series design on 2,703 unique products ...
By January 2020, the average price per ounce of SSBs increased by 26.0%, while the price of untaxed beverages (including waters and non-added sugar drinks) remained constant. The increasing price of S...
The tax was largely passed through to consumers. However, several factors mitigated the impact of the tax on the prices paid for SSBs by consumers, including the specific design of the tax, price prom...
A male is less adaptable to biological stressors than a female fetus with consequent higher morbidity and mortality. Adverse birth outcomes increase and male livebirths decrease after environmental di...
Interrupted time series analysis was used to analyze Queensland administrative birth records from July 2007 to June 2018 for significant changes in the sex ratio at birth, measured as the proportion o...
Contrary to our hypothesis, increases in the proportion of male livebirths were observed following early-pregnancy exposure to cyclone Yasi and mid-pregnancy exposure to Marcia, although the latter wa...
This study found a significant association between severe TCs and sex ratio at birth. The stage of pregnancy at which maternal stressors were experienced modified this association. Among people expose...
